Clinical Trial

Clouds of Care Secures 5 Million Euros to Propel CNS Healthcare Innovation and appoints former CEO of Biogen, Michel Vounatsos, as chairman of the board of directors

GHENT, Belgium, Sept. 4, 2024 /PRNewswire/ -- Clouds of Care, a leading MedTech company dedicated to enabling better care for people with…

1 year ago

Phesi Receives Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform

Phesi's Trial Accelerator™ Platform empowers trial sponsors to make informed decisions swiftly, expediting drug development timelines while upholding the highest…

1 year ago

HealthVerity introduces taXOnomy℠, the nation’s most comprehensive closed (X) and open (O) claims dataset for pharmaceutical research

PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the…

1 year ago

Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network

Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on…

1 year ago

EmVenio Research joins SCRS as Global Impact Partner

Research organization has been active SCRS member since 2022 founding DURHAM, N.C., Sept. 4, 2024 /PRNewswire/ -- Clinical research organization…

1 year ago

Lindus Health Launches “All-in-One Ophthalmology CRO” Tailored to Clinical Trials in Ophthalmology

NEW YORK, Sept. 4, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life…

1 year ago

Waterdrop Inc. Announces Second Quarter 2024 Unaudited Financial Results and a Special Cash Dividend

BEIJING, Sept. 4, 2024 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated…

1 year ago

Stemtech Corporation Announces Uplist to OTCQB, Maintains Focus on Expansion and Transparency

NAPLES, FL / ACCESSWIRE / September 4, 2024 / ("STEK") Stemtech Corporation, the pioneer and trailblazer in the stem cell…

1 year ago

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications

MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company…

1 year ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second…

1 year ago